Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 12:31 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1057–1080 of 46,477 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Intervention/procedure Clear all

Conditions: Posttraumatic Stress Disorder
Interventions: Loved one assisted treatment; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 3
States / cities: Decatur, Georgia • Ann Arbor, Michigan • Minneapolis, Minnesota

Conditions: Firearm Injury, Economic Problems, Injury Traumatic
Interventions: Recovery Legal Care, HVIP Standard of Care; Other
Lead sponsor: University of Chicago; Other
Eligibility: 14 Years and older
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Colon Cancer, Colon Polyp, Diverticular Diseases, Inflammatory Bowel Diseases
Interventions: VI-RASD use in minimally invasive right or left colectomy, Right or Left colectomy; Device · Procedure
Lead sponsor: Virtual Incision Corporation; Industry
Eligibility: 22 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 3
States / cities: Lincoln, Nebraska • Wynnewood, Pennsylvania • Mt. Pleasant, South Carolina

Conditions: Mantle Cell Lymphoma
Interventions: Bendamustine, Rituximab, Cytarabine, Pegfilgrastim, Leukapheresis, Filgrastim, Autologous stem cell transplant; Drug · Procedure
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Ureteral Stricture, Hydronephrosis, Urothelial Carcinoma, Urolithiasis
Interventions: Water, Saline; Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Social Anxiety
Interventions: Internet-delivered self-help for social anxiety based on principles of cognitive behavioral therapy; Behavioral
Lead sponsor: Trustees of Princeton University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Princeton, New Jersey

Conditions: Hypertension
Interventions: Health Literacy-focused Self-help, Delayed Intervention Control; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 198 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Metastatic Melanoma
Interventions: Surgery, Administration of Lymphodepletion, Adoptive Cell Transfer, High Dose IL-2; Procedure · Drug · Other
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2025
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Urologic Diseases, Antibacterial Drug Adverse Reaction
Interventions: Audit-and-feedback; Behavioral
Lead sponsor: Iowa City Veterans Affairs Medical Center; Federal
Eligibility: Not listed
Enrollment: 525 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 3
States / cities: Gainesville, Florida • Iowa City, Iowa • New York, New York

Conditions: Hepatitis C, Hepatitis C Virus Infection, Response to Therapy of
Interventions: glecaprevir/pibrentasvir (GLE/PIB); Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: San Diego, California

Conditions: Colorectal Cancer
Interventions: celecoxib, fluorouracil, conventional surgery, radiation therapy, tumor biopsy, laboratory biomarker analysis; Drug · Procedure · Radiation + 1 more
Lead sponsor: Vanderbilt-Ingram Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2008
U.S. locations: 2
States / cities: Nashville, Tennessee

Conditions: Attention Deficit Disorder With Hyperactivity, Asthma, COPD, Breast Cancer, Coronary Artery Disease, Congestive Heart Failure, Diabetes, Glaucoma, Hemophilia, Hypertension, Hyperthyroidism, Hypothyroidism, Myasthenia Gravis, Osteoporosis, Osteopenia, Renal Failure, Renal Insufficiency, Sickle Cell Disease, Stroke
Interventions: MAPLE; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2017
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: CVD, Cardiovascular Diseases
Interventions: Hoosier Sport; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 10 Years to 18 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Bloomington, Indiana • Lyons, Indiana

Conditions: Prader-Willi Syndrome
Interventions: Oxytocin, Placebo; Drug
Lead sponsor: University of Florida; Other
Eligibility: 1 Week to 6 Months
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Rib Fractures
Interventions: Suzetrigine (SUZ), Placebo; Drug
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Orange, California

Conditions: Sedentary Lifestyle
Interventions: i-STAND, Healthy Living control; Behavioral · Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 60 Years to 89 Years
Enrollment: 283 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Gut Microbiomes
Interventions: Grape Powder, Placebo Powder; Dietary Supplement · Other
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 45 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Multiple System Atrophy - Parkinsonian Subtype (MSA-P), Multiple System Atrophy - Cerebellar Subtype (MSA-C)
Interventions: Not listed
Lead sponsor: University of Michigan; Other
Eligibility: 30 Years to 80 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Congestive Heart Failure
Interventions: Ultrafiltration, Ultrafiltration using BVM; Other
Lead sponsor: Christiana Care Health Services; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Bladder Cancer, Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy), Non-muscle Invasive Bladder Cancer (NMIBC), Non-Muscle Invasive Bladder Neoplasms, Non-muscle Invasive Bladder Cancer, Bladder Cancer (BC), Transurethral Resection of Bladdertumors, Transurethral Resection of the Bladder, Non-Muscle Invasive Bladder Carcinoma
Interventions: HISA; Device
Lead sponsor: CAMC Health System; Other
Eligibility: 18 Years to 89 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Charleston, West Virginia

Conditions: Control Condition, Intervention Condition
Interventions: Collaborative Life Skills; Behavioral
Lead sponsor: San Diego State University; Other
Eligibility: 7 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: San Diego, California

Conditions: Exposure
Interventions: Not listed
Lead sponsor: Baptist Health South Florida; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Myopia
Interventions: LASIK; Procedure
Lead sponsor: Stanford University; Other
Eligibility: Not listed
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Stanford, California

Conditions: Non Small Cell Lung Cancer
Interventions: Photodynamic Therapy, Argon Plasma Coagulation; Procedure
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 99 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Gainesville, Florida

Search by objective public record fields.

Teaching Loved Ones to Help Veterans Optimize Their PTSD Care and Healing

Recovery Legal Care Pilot

Virtual Incision Robotically Assisted Surgical Device Use in Minimally Invasive Colectomy

Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma

Water Versus Saline as Irrigation Fluid for Ureteroscopy

Online Study on the Impact of a Self-Help Tool for Social Anxiety

Understanding Health Care Information for African Americans With High Blood Pressure

Lymphodepletion Plus Adoptive Cell Transfer With High Dose IL-2 in Patients With Metastatic Melanoma

Audit-and-feedback to Improve Antimicrobial-prescribing Among Urologists

Prevention of Transmission of Hepatitis C Virus (HCV) From HCV-Viremic Organ Donor

Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery

Study of an Intervention to Improve Problem List Accuracy and Use

Hoosier Sport: Refining and Implementing a Sustainable Campus-Community Partnership in Rural Indiana

Intranasal Oxytocin for Infants With Prader-Willi Syndrome

Suzetrigine for Acute Pain Control in Patients With Multiple Rib Fractures

Healthy Aging Resources to Thrive (HART)

Grape Impact on Human Gut Microbiome

PET Imaging Study of Neurochemical and Autonomic Disorders in Multiple System Atrophy (MSA)

Utilizing Blood Volume Measurements in the Treatment of Heart Failure Patients

Feasibility of HISA During TURBT for NMIBC

Reducing Disparities in Access to Evidence-Based Services for Attention Deficit Hyperactivity Disorder (ADHD) Through Technology

New Fabric Attenuation Device in Endovascular Interventional Radiology (PREFER)

Effect of Preoperative Pupil Size on Quality of Vision After Wavefront-Guided LASIK

Trial of Photodynamic Therapy Versus Argon Plasma Coagulation for Lung Cancer With Endobronchial Obstruction